-transparent.png){kind=logo}
A placebo-controlled, prospective study was undertaken to determine whether apraclonidine has an additive effect in eyes treated with timolol and pilocarpine. Twelve patients with primary open-angle glaucoma while on continuing therapy with timolol 0.5% twice daily and pilocarpine 4% four times a day in both eyes for 3 months were included in the study. A single drop of apraclonidine 1% or placebo was added to treatment with timolol and pilocarpine. Intraocular pressure (IOP) was measured on both days before a single drop of test medications in both eyes as well as 2, 4, 6, 8 and 12 h later. The fall in IOP with apraclonidine was significantly greater than with placebo at all time intervals (p < 0.05). This study suggests that apraclonidine provides an additive IOP-lowering effect to timolol and pilocarpine for at least 12 h after single-drop applications.
N Yüksel, and
O Elibol, and
Y Caglar, and
T Alçelik
January 1993,
Journal of glaucoma,
N Yüksel, and
O Elibol, and
Y Caglar, and
T Alçelik
October 1993,
Acta ophthalmologica,
N Yüksel, and
O Elibol, and
Y Caglar, and
T Alçelik
October 1991,
Ophthalmology,
N Yüksel, and
O Elibol, and
Y Caglar, and
T Alçelik
September 1976,
Investigative ophthalmology,
N Yüksel, and
O Elibol, and
Y Caglar, and
T Alçelik
January 2002,
Eye (London, England),
N Yüksel, and
O Elibol, and
Y Caglar, and
T Alçelik
September 1993,
Ophthalmic surgery,
N Yüksel, and
O Elibol, and
Y Caglar, and
T Alçelik
April 2022,
Journal of equine veterinary science,
N Yüksel, and
O Elibol, and
Y Caglar, and
T Alçelik
June 1991,
Archives of ophthalmology (Chicago, Ill. : 1960),
N Yüksel, and
O Elibol, and
Y Caglar, and
T Alçelik
June 2006,
American journal of ophthalmology,
N Yüksel, and
O Elibol, and
Y Caglar, and
T Alçelik
May 1992,
Archives of ophthalmology (Chicago, Ill. : 1960),
